HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

sipuleucel-T (APC8015)

consists of CD54-positive PA2024-loaded antigen presenting cells with admixtures of monocytes, macrophages, and B and T cells; proposed prostate cancer vaccine
Also Known As:
APC8015; Provenge; APC 8015; APC-8015
Networked: 432 relevant articles (62 outcomes, 93 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Drake, Charles G: 21 articles (01/2022 - 05/2010)
2. Small, Eric J: 21 articles (01/2021 - 06/2005)
3. Gulley, James L: 21 articles (01/2020 - 01/2010)
4. Kantoff, Philip W: 20 articles (01/2020 - 07/2010)
5. Fong, Lawrence: 18 articles (01/2021 - 07/2006)
6. Higano, Celestia S: 17 articles (01/2020 - 07/2006)
7. Madan, Ravi A: 16 articles (01/2020 - 01/2010)
8. Shore, Neal D: 15 articles (01/2020 - 07/2010)
9. Antonarakis, Emmanuel S: 13 articles (10/2021 - 05/2010)
10. Sheikh, Nadeem A: 12 articles (01/2022 - 01/2013)

Related Diseases

1. Prostatic Neoplasms (Prostate Cancer)
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Disease Progression
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. cabazitaxel
2. Vaccines
3. enzalutamide
4. abiraterone
5. Abiraterone Acetate
6. sipuleucel-T (APC8015)
7. Androgens
8. Radium-223
9. Docetaxel (Taxotere)
10. Ipilimumab

Related Therapies and Procedures

1. Castration
2. Immunotherapy
3. Therapeutics
4. Drug Therapy (Chemotherapy)
5. Radiotherapy